- Novo Nordisk Shares Plummet as Competition Weighs on Sales The Wall Street Journal
- Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning The New York Times
- Novo Nordisk outgoing CEO blames compounded GLP-1s for decline in 2025 outlook Yahoo Finance
- Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance CNBC
- Novo Stock (NVO) Tumbles. Ozempic, Wegovy Maker Has New CEO, Cuts U.S. Outlook Barron’s
Source link
